CCND1 and ductal breast carcinoma in situ: A separate investigation determined the cyclin D1 positivity in proliferative disease without atypia, atypical ductal hyperplasia, low-grade ductal carcinoma in situ (DCIS), high-grade DCIS, and invasive carcinoma.